MedPath

DNK-PEDFLU-2

Phase 2
Conditions
Prevention of influenza infection
Registration Number
JPRN-jRCT2080221243
Lead Sponsor
DENKA SEIKEN CO.,LTD.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Sex
All
Target Recruitment
40
Inclusion Criteria

Healthy Child

Exclusion Criteria

Known history of influenza or received influenza vaccination within six months.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
safety and immunogenicity<br>Adverse Event<br>HI antibody titer against antigen
Secondary Outcome Measures
NameTimeMethod
immunogenicity <br>Neutralizing antibody titer against influenza virus
© Copyright 2025. All Rights Reserved by MedPath